AlnusonolCAS# 52330-12-8 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 52330-12-8 | SDF | Download SDF |
PubChem ID | 14009033 | Appearance | Powder |
Formula | C19H20O4 | M.Wt | 312.4 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3,11,17-trihydroxytricyclo[12.3.1.12,6]nonadeca-1(17),2,4,6(19),14(18),15-hexaen-9-one | ||
SMILES | C1CC2=CC(=C(C=C2)O)C3=C(C=CC(=C3)CCC(=O)CC1O)O | ||
Standard InChIKey | XVHOPVJSRBYOKK-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H20O4/c20-14-5-1-12-3-7-18(22)16(9-12)17-10-13(4-8-19(17)23)2-6-15(21)11-14/h3-4,7-10,14,20,22-23H,1-2,5-6,11H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Alnusonol Dilution Calculator
Alnusonol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.201 mL | 16.0051 mL | 32.0102 mL | 64.0205 mL | 80.0256 mL |
5 mM | 0.6402 mL | 3.201 mL | 6.402 mL | 12.8041 mL | 16.0051 mL |
10 mM | 0.3201 mL | 1.6005 mL | 3.201 mL | 6.402 mL | 8.0026 mL |
50 mM | 0.064 mL | 0.3201 mL | 0.6402 mL | 1.2804 mL | 1.6005 mL |
100 mM | 0.032 mL | 0.1601 mL | 0.3201 mL | 0.6402 mL | 0.8003 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Carpinontriol A
Catalog No.:BCN9238
CAS No.:473451-72-8
- Qingyangshengenin 3-O-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-digitoxopyranoside
Catalog No.:BCN9237
CAS No.:1186628-88-5
- (R)-4-Methoxydalbergione
Catalog No.:BCN9236
CAS No.:4646-86-0
- 2-(2,4-Dihydroxybenzoyl)benzoic acid
Catalog No.:BCN9235
CAS No.:2513-33-9
- 4-Hydroxy-2,3-dimethoxyxanthone
Catalog No.:BCN9234
CAS No.:10527-38-5
- Rhamnazin
Catalog No.:BCN9233
CAS No.:552-54-5
- Sonnerphenolic B
Catalog No.:BCN9232
CAS No.:1627516-10-2
- Axinysone A
Catalog No.:BCN9231
CAS No.:1114491-57-4
- N-Acetyldelectine
Catalog No.:BCN9230
CAS No.:63596-61-2
- (-)-Episyringaresinol
Catalog No.:BCN9229
CAS No.:6216-82-6
- Glabredelphinine
Catalog No.:BCN9228
CAS No.:132160-37-3
- Delbonine
Catalog No.:BCN9227
CAS No.:95066-33-4
- Sepiumol C
Catalog No.:BCN9240
CAS No.:2412138-09-9
- Periplanetin
Catalog No.:BCN9241
CAS No.:21056-52-0
- Otophylloside T
Catalog No.:BCN9242
CAS No.:1642306-14-6
- Cinchonain Ia
Catalog No.:BCN9243
CAS No.:85081-24-9
- Lehmbachol D
Catalog No.:BCN9244
CAS No.:913556-40-8
- Dehydrojuncuenin A
Catalog No.:BCN9245
CAS No.:1161681-26-0
- Periplocoside O
Catalog No.:BCN9246
CAS No.:116709-67-2
- Qingyangshengenin 3-O-β-D-cymaropyranosyl-(1→4)-β-D-digitoxopyranoside
Catalog No.:BCN9247
CAS No.:1186628-87-4
- Dictysine
Catalog No.:BCN9248
CAS No.:67256-05-7
- Murrayanine
Catalog No.:BCN9249
CAS No.:723-97-7
- Dauricumine
Catalog No.:BCN9250
CAS No.:345641-00-1
- 1,6-Dimethyl-5-vinyl-9,10-dihydrophenanthren-2-ol
Catalog No.:BCN9251
CAS No.:745056-83-1
Cyclic diarylheptanoids from Myrica nana inhibiting nitric oxide release.[Pubmed:18723353]
Bioorg Med Chem. 2008 Sep 15;16(18):8510-5.
Investigation of the roots of Myrica nana afforded five new cyclic diarylheptanoids, myricananins A-E (1-5), two new artifacts of myricananins A and B (6-7), and four known compounds, 12-hydroxymyricanone (8), Alnusonol (9), myricatomentogenin (10), and actinidione (11). The structures of these new compounds were established by detailed spectroscopic methods. The stereochemistry of compounds 1 and 2 were determined by single-crystal X-ray diffraction. In exception of compounds 2, 6 and 10, all the other compounds were examined for their inhibitory effects on nitric oxide production in lipopolysaccharides-activated macrophages. Compounds 1, 3, 7, 8 and 9 inhibited the release of nitric oxide with IC(50) values of 45.32, 63.51, 52.81, 30.19 and 46.18muM, respectively. Furthermore, compound 1 was found to inhibit the expression of inducible nitric oxide synthase.